NASDAQ · Analyst Forecast

Tenax Therapeutics, Inc. (TENX) Stock Forecast & Price Target

$1.42 NASDAQ: TENX Market Cap $37.67M

Price as of Nov 17, 2026 close · Analyst estimates retrieved Nov 15, 2026 · Source: Financial Modeling Prep (analyst estimates) (methodology)

Revenue and earnings estimates published by analysts covering Tenax Therapeutics, Inc. (TENX), and the range of their price targets. Everything on this page is a forecast made by other people — DeltaScreener does not produce estimates or targets of its own.

For Tenax Therapeutics, Inc., analysts forecast revenue rising from $2.00M in 2025 to $114.25M in 2030; the average estimate for 2030 earnings per share is −$0.57; 9 analysts contribute to these figures. These are forecasts published by analysts, not results.

Analyst price targets

MeasureValue
Current priceWhat the share trades at now.$1.42
Consensus targetThe average of the price targets analysts have published.$4.40
Median targetThe middle target, less affected by a single outlier.$4.00
Highest targetThe most optimistic published target.$5.00
Lowest targetThe most pessimistic published target.$4.00
Difference from priceHow far the consensus target sits from today’s price.+209.9%

A price target is one analyst's forecast of where a share might trade, usually over twelve months. Targets are frequently revised, they disagree with each other, and they are not a measure of what a company is worth.

Revenue forecast (USD)

The spread between low and high is how far analysts disagree, which is usually a better guide than the average alone.

YearLowAverageHighAnalysts
2025$2.00M$2.00M$2.00M5
2026$4.16M$4.16M$4.16M8
2027$12.90M$12.90M$12.90M9
2028$26.67M$26.67M$26.67M9
2029$37.33M$37.33M$37.33M4
2030$114.25M$114.25M$114.25M4

Earnings per share forecast

YearLowAverageHighAnalysts
2025−$1.39−$1.37−$1.365
2026−$1.51−$1.39−$1.188
2027−$1.53−$1.31−$1.079
2028−$1.78−$1.28−$0.599
2029−$1.07−$1.07−$1.074
2030−$0.57−$0.57−$0.574

Tenax Therapeutics, Inc. (TENX) forecast — frequently asked questions

What is the analyst price target for Tenax Therapeutics, Inc.?

Analysts covering Tenax Therapeutics, Inc. (TENX) have a consensus price target of $4.40, 209.9% above the current price of $1.42. Published targets range from $4.00 to $5.00. A price target is a forecast, not a measure of value, and targets are revised often.

What are analysts forecasting for Tenax Therapeutics, Inc.'s earnings?

The average analyst estimate for Tenax Therapeutics, Inc. (TENX) earnings per share in 2030 is -0.57, with individual estimates between -0.57 and -0.57.

How much revenue is Tenax Therapeutics, Inc. expected to make?

Analysts forecast Tenax Therapeutics, Inc. (TENX) revenue of $114.25M in 2030, based on 4 published estimates.

How many analysts cover TENX?

9 analysts contribute estimates for Tenax Therapeutics, Inc. (TENX). Thin coverage makes an average less reliable.

Analyst forecasts for other Biotechnology stocks

VRTX forecastREGN forecastMRNA forecastRVMD forecastROIV forecastINSM forecastUTHR forecastINCY forecastALNY forecastASND forecastAll Biotechnology stocks

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNasdaq High ROE StocksAll stock screens

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.